Synthesis and inhibitory properties of (1R,2R,4R,6 R)-6-O -(2-hydroxyethyl)cyclohexane-1,2,4,6-tetraol derivatives: mechanistic probes for the inositol monophosphatase reaction 1

Abstract

The phosphate derivatives 2, 3 and 4 of 6-O-(2-hydroxyethyl)cyclohexane-1,2,4,6-tetraol have been designed to inhibit inositol monophosphatase, the putative target for lithium therapy, by interacting simultaneously with both cofactor metal ions at the active site of the enzyme. The compounds have been synthesised, via the known key common intermediate cyclohexene oxide, from cyclohexane-1,4-diol in moderate yield, and have been tested for activity in standard enzyme assays. Each compound serves as a competitive inhibitor and displays the expected inhibitory properties. Indeed, compound 4 and the cyclic phosphate 3 of 6-O-(2-hydroxyethyl)cyclohexane-1,2,4,6-tetraol are, respectively, the most potent examples of a primary alkyl phosphate inhibitor and a phosphate monoanion inhibitor yet reported for the enzyme. The stereochemistry of the most potent inhibitor, (1R,2R,4R,6R)-2 as deduced from the X-ray crystal structure of a synthetic precursor, provides useful mechanistic insight into the action of the enzyme and the mode of inhibitor binding.

References

1. J. Schulz, J. Wilkie, P. Lightfoot, T. Rutherford and D. Gani, J. Chem. Soc., Chem. Commun., 1995, 2353.
2. M. J. Berridge and R. F. Irvine, Nature (London), 1989, 341, 197.
3. D. Gani, C. P. Downes, I. Batty and J. Bramham, Biochim. Biophys. Acta, 1993, 1177, 253.
4. B. V. L. Potter and D. Lampe, Angew. Chem., Int. Ed. Engl., 1995, 34, 1933.
5. A. Kishimoto, Y. Takai, T. Mori, U. Kikkawa and Y. Nishizuka, J. Biol. Chem., 1980, 255, 2273.
6. Y. Nishizuka, Nature (London), 1984, 308, 693.
7. E. H. Fischer, Angew. Chem., Int. Ed. Engl., 1993, 32, 1130.
8. H. Streb, R. F. Irvine, M. J. Berridge and I. Schulz, Nature (London), 1983, 306, 67.
9. R. Spector and A. V. Lorenzo, Am. J. Physiol., 1975, 228, 1510.
10. J. H. Allison and M. A. Stewart, Nature (London), 1971, 233, 267.
11. J. H. Allison, M. E. Blisner, W. H. Holland, P. P. Hipps and W. R. Sherman, Biochem. Biophys. Res. Commun., 1976, 71, 664.
12. L. M. Hallcher and W. R. Sherman, J. Biol. Chem., 1980, 255, 10 896.
13. K. Takimoto, M. Okada, Y. Matsuda and H. Nakagawa, J. Biochem. (Tokyo), 1985, 98, 363.
14. N. S. Gee, C. I. Ragan, K. J. Watling, S. Aspley, R. G. Jackson, G. G. Reid, D. Gani and J. K. Shute, Biochem. J., 1988, 249, 883.
15. J. K. Shute, R. Baker, D. C. Billington and D. Gani, J. Chem. Soc., Chem. Commun., 1988, 626.
16. P. W. Attwood, J.-B. Ducep and M. C. Chanal, Biochem. J., 1988, 253, 387.
17. A. J. Ganzhorn and M. C. Chanal, Biochemistry, 1990, 29, 6065.
18. A. P. Leech, G. R. Baker, J. K. Shute, M. A. Cohen and D. Gani, Eur. J. Biochem., 1993, 212, 693.
19. A. Cole and D. Gani, J. Chem. Soc., Chem. Commun., 1994, 1139.
20. P. D. Leeson, K. James, I. C. Lennon, N. J. Liverton, S. Aspley and R. G. Jackson, Bioorg. Med. Chem. Lett., 1993, 3, 1925.
21. P. J. Greasley and M. G. Gore, FEBS Lett., 1993, 331, 114.
22. S. J. Pollack, J. R. Atack, M. R. Knowles, G. McAllister, C. I. Ragan, R. Baker, S. R. Fletcher, L. L. Iverson and H. B. Broughton, Proc. Natl. Acad. Sci. USA, 1994, 91, 5766.
23. S. J. Pollack, M. R. Knowles, J. R. Atack, H. B. Broughton, C. I. Ragan, S. A. Osborne and G. McAllister, Eur. J. Biochem., 1993, 217, 281.
24. R. Bone, L. Frank, J. P. Springer, S. J. Pollack, S. A. Osborne, J. R. Atack, M. R. Knowles, G. McAllister, C. I. Ragan, H. B. Broughton, R. Baker and S. R. Fletcher, Biochemistry, 1994, 33, 9460.
25. J. Wilkie, A. G. Cole and D. Gani, J. Chem. Soc., Perkin Trans. 1, 1995, 2709.
26. R. Baker, P. D. Leeson, N. J. Liverton and J. J. Kulagowski, J. Chem. Soc., Chem. Commun., 1990, 462.
27. R. Baker, J. J. Kulagowski, D. C. Billington, P. D. Leeson, I. C. Lennon and N. Liverton, J. Chem. Soc., Chem. Commun., 1989, 1383.
28. R. Baker, C. Carrick, P. D. Leeson, I. C. Lennon and N. J. Liverton, J. Chem. Soc., Chem. Commun., 1991, 298.
29. G. R. Baker and D. Gani, Bioorg. Med. Chem. Lett., 1991, 1, 193.
30. A. G. Cole and D. Gani, J. Chem. Soc., Perkin Trans. 1, 1995, 2685.
31. A. G. Cole, J. Wilkie and D. Gani, J. Chem. Soc., Perkin Trans. 1, 1995, 2695.
32. R. Bone, J. P. Springer and J. R. Atack, Proc. Natl. Acad. Sci. USA, 1992, 89, 10 031.
33. R. Bone, L. Frank, J. P. Springer and J. R. Atack, Biochemistry, 1994, 33, 9468.
34. D. Gani and J. Wilkie, Chem. Soc. Rev., 1995, 24, 55.
35. J. Wilkie and D. Gani, J. Chem. Soc., Perkin Trans. 2, 1996, 783.
36. C. J. Godek, R. Y. Moir and C. B. Purves, Can. J. Chem., 1951, 29, 946.
37. D. A. Prins, Helv. Chim. Acta., 1957, 40, 1621.
38. M. Chini, P. Crotti, L. A. Flippin and F. Macchia, J. Org. Chem., 1990, 55, 4265.
39. K. B. Sharpless and R. F. Lauer, J. Am. Chem. Soc., 1973, 95, 2697.
40. H. Suemune, K. Matsuno, M. Uchida and K. Sakai, Tetrahedron: Asymmetry, 1992, 3, 297.
41. S. V. Ley, M. Parra, A. J. Redgrave and F. Sternfeld, Tetrahedron, 1990, 46, 4995.
42. S. V. Ley and F. Sternfeld, Tetrahedron, 1989, 45, 3463.
43. A. Brandes, U. Eggert and H. M. R. Hoffmann, Synlett, 1994, 745.
44. J. P. Vacca, S. Jane deSolms, J. R. Huff, D. C. Billington, J. J. Kulagowski and J. M. Mawer, Tetrahedron, 1989, 45, 5679.
45. I. Schön, Chem. Rev., 1984, 84, 287.
46. K. Horita, T. Yoshioka, T. Tanaka, Y. Oikawa and O. Yonemitsu, Tetrahedron, 1986, 42, 3021.
47. A. M. P. van Steijn, H. A. M. Willems, Th. de Boer, J. L. T. Geurts and C. A. A. van Boeckel, Bioorg. Med. Chem. Lett., 1995, 5, 469.
48. G. R. Baker, D. C. Billington and D. Gani, Tetrahedron, 1991, 47, 3895.
49. D. D. Perrin, W. L. F. Armarego and D. R. Perrin, Purification of Laboratory Chemicals, Pergamon Press, Oxford, 1980.
50. D. C. Billington, R. Baker, J. J. Kulagowski and J. M. Mawer, J. Chem. Soc., Chem. Commun., 1987, 314.
51. R. E. Diehl, P. Whiting, J. Potter, N. S. Gee, C. I. Ragan, D. Linemeyer, R. Schoepfer, C. Bennett and R. A. F. Dixon, J. Biol. Chem., 1990, 265, 5946.
52. K. Itaya and M. Ui, Clin. Chim. Acta, 1966, 14, 361.